Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
80%
Ph early_phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (20.0%)
N/A4 (80.0%)

Trials by Status

completed120%
unknown360%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
completedearly_phase_1

NeuroGlove PD Study Clinical

NCT06578273
unknownnot_applicable

NeuroGlove PTSD Study

NCT06050590
unknownnot_applicable

NeuroGlove fMRI Study

NCT05961293
withdrawnnot_applicable

A Functional MRI Study: Assessing Brain Function in Post Stoke Patients

NCT06573840
unknownnot_applicable

NeuroGlove Anxiety and Depression Study

NCT06065787

Clinical Trials (5)

Showing 5 of 5 trials
NCT06578273Early Phase 1

NeuroGlove PD Study Clinical

Completed
NCT06050590Not Applicable

NeuroGlove PTSD Study

Unknown
NCT05961293Not Applicable

NeuroGlove fMRI Study

Unknown
NCT06573840Not Applicable

A Functional MRI Study: Assessing Brain Function in Post Stoke Patients

Withdrawn
NCT06065787Not Applicable

NeuroGlove Anxiety and Depression Study

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5